GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangzhou Kingmed Diagnostics Group Co Ltd (SHSE:603882) » Definitions » Cyclically Adjusted Price-to-FCF

Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Cyclically Adjusted Price-to-FCF : 35.11 (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted Price-to-FCF?

As of today (2024-12-14), Guangzhou Kingmed Diagnostics Group Co's current share price is ¥32.65. Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was ¥0.93. Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF for today is 35.11.

The historical rank and industry rank for Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:603882' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.51   Med: 91.32   Max: 161.41
Current: 36.51

During the past 12 years, Guangzhou Kingmed Diagnostics Group Co's highest Cyclically Adjusted Price-to-FCF was 161.41. The lowest was 36.51. And the median was 91.32.

SHSE:603882's Cyclically Adjusted Price-to-FCF is ranked worse than
59.38% of 64 companies
in the Medical Diagnostics & Research industry
Industry Median: 31.805 vs SHSE:603882: 36.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Guangzhou Kingmed Diagnostics Group Co's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was ¥1.107. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.93 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted Price-to-FCF Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 161.26 85.79 67.22

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 67.22 - - -

Competitive Comparison of Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF falls into.



Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=32.65/0.93
=35.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Guangzhou Kingmed Diagnostics Group Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=1.107/114.7809*114.7809
=1.107

Current CPI (Dec23) = 114.7809.

Guangzhou Kingmed Diagnostics Group Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 99.000 0.000
201512 -0.334 100.600 -0.381
201612 -0.356 102.600 -0.398
201712 -0.235 104.500 -0.258
201812 0.401 106.500 0.432
201912 0.845 111.200 0.872
202012 2.106 111.500 2.168
202112 2.435 113.108 2.471
202212 2.372 115.116 2.365
202312 1.107 114.781 1.107

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Guangzhou Kingmed Diagnostics Group Co  (SHSE:603882) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Guangzhou Kingmed Diagnostics Group Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Guangzhou Kingmed Diagnostics Group Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Kingmed Diagnostics Group Co Business Description

Traded in Other Exchanges
N/A
Address
International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2023, KingMed has 49 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
Executives
Hao Bi Xi Directors, senior managers
Wang Ling Lai Director
Yu Shi Hui senior management
Liang Yao Ming Director
Peng Yong Xiang Director

Guangzhou Kingmed Diagnostics Group Co Headlines

No Headlines